Multiple organ failure - The discrepancy between our scientific knowledge and understanding and the management of our patients

Langenbeck's Archives of Surgery

Volumn 385, Issue 7, 2000, Pages 441-453

  Baue, E ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIVERTICULOSIS; EXPERIMENTATION; GENDER; GENETIC ANALYSIS; HUMAN; INFLAMMATION; LIFESTYLE; MULTIPLE ORGAN FAILURE; PANCREATITIS; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SEPSIS; TREATMENT OUTCOME;

EID: 0033697353     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230000162     Document Type: Review

References (129)

1. Scott-Burden T (1999) Nitric oxide leads to prized nobility. Texas Heart InstJ26:l-6
2. Avontuur JAM, Tutein Nolthenius RP, van Bodegom JW, Bruining HA (1998 Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clin ical study. Crit Care Med 26:660-667
3. Petros A, Bennett D, Vallance P (1991 Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557-1558
4. Grover R, Lopez A, Lorente J, Steingrub J, Bakker J, Williatts S, McLuckie A, Takala J (1999) Multicenter, randomized placebo-controlled double-blind study of the nitric oxide synthase inhibitor 546C88. Crit Care Med27(Suppl 1):A33
5. Bloom F (2000) The endless pathways of discovery. Science 287:229
6. Osier W (1909) The Principles and Practice of Medicine, 7th edn. D. Appleton, New York
7. Sh Q, Fang XM, Daufeldt S, Allera A, Putensen C, Hoeft A, Stuber F (1999) Association of tumor necrosis factor microsatellites with incidence and outcome of severe sepsis. Crit Care Med 27 (Suppl):A49
8. Baue AE (1975) Multiple, progressive or sequential systems failure: a syndrome of the 1970s. Arch Surg 110:779-781
9. Faist E, Baue AE, Dittmer H, Heberer G (1983) Multiple organ failure in polytrauma patients. J Trauma 23:775-787
10. Faist E, Heberer G, Baue AE (1983) Das Mehrorganversagen beim polytraumatisierten Patienten. Krankenhausarzt 56:1-14
11. Beale R, Bihari DJ (1993) Multiple organ failure: the pilgrim's progress. Crit Care Med 21:51-53
12. Baue AE (1993) The role of the gut in the development of multiple organ dys function in cardiothoracic patients. Ann Thorac Surg 55:822-829
13. ACCP/SCCM Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874.
14. Goris RJA (1996) MODS/SIRS: result of an overwhelming inflammatory response. World J Surg 20:418-421
15. Dellinger RP, Bone RC (1998) To SIRS with love. Crit Care Med 26:178-179
16. Vincent JL (1997) Dear SIRS, I'm sorry to say I don't like you. Crit Care Med 25:372-374
17. Baue AE (1993) What's in a name? An acronym or a response? Am J Surg 165:299-301
18. Jones GR, Lowes JA (1996) The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis. Q J Med 89:515-522
19. Blakiston's Gould Medical Dictionary (1972) Blakiston's Gould medical dictionary, 3rd edn, Mc-Graw Hill, New York
20. Baue AE (2000) SIRS, MODS, MOF what's in a name? Shock (In press)
21. Goris RJA, Bockhorst GE, Nuytinck TPA (1985) Multiple organ failure: generalized and destructive inflammation. Arch Surg 120:1109-1115
22. Hunter J (1794) Treatise on the Blood Inflammation and Gunshot Wounds, 2nd edn. James Webster, London
23. Ehrlich P, Morgenroth J (1901) Ueber Hämolysins. Fünfte Mittel lung. Berl Klin Wochenschr 38:251-257
24. Opal SM (1999) Clinical trials for severe sepsis: past failures and future hopes. Infect Dis Clin North Am 13:285-297
25. Eidelman LA, Sprung CL (1994) Why have new effective therapies for sepsis not been developed? Crit Care Med 22:1330-1334
26. Bone RC (1996) Why sepsis trials fail. JAMA 276:565-566
27. Zeni F, Freeman B, Natanson C (1997) Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 25:1095-1100
28. Baue AE (1997) MOF, MODS and SIRS - why no magic bullets? Arch Surg 132:703-707
29. Cohn SM (1999) Blood substitutes. New Horizons 7:54-60
30. Suter PM, Domenighetti G, Schaller M-D, Laverrière M-C, Ritz R, Perret C (1994) N-acetylcysteine enhances recovery from acute lung injury in man: a randomized, double-blind, placebo-controlled clinical study. Chest 105:190-194
31. Gura T (2000) Tracing leptins partners in regulating body weight. Science 287:1738-1741
32. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, DuPont WD, Higgins SB, Swindell BB (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. New Engl J Med 336:912-918
33. Waydhas C, Nast-Kolb D, GippnerSteppert C, Trupka A, Pfundstein C, Schweiberer L, Jochum M (1998) High-dose antithrombin III treatment of severely injured patients: results of a prospective study. J Trauma 45:931-940
34. Vincent J-L, Spapen H, Bakker J, Webster NR, Curtis L (2000) Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis. Crit Care Med 28:638-642
35. Agosti JM, Fisher JC, Opal SM (1994) Treatment of patients with sepsis syndrome with soluble TNF receptor (sTNFr). Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents (Abstract M3)
36. Goldfarb R (1999) Investigations into the polydeterminant nature of sepsis. Crit Care Med 27: 2587-2590
37. Stehbens WE (1992) Causality in medical science with particular reference to heart disease and atherosclerosis. PerspectBiol Med 36:97-119
38. Stehbens WE (1985) The concept of cause in disease. J Chronic Dis 38:947-950
39. Abraham E, Matthay MA, Dinarello CA, Vincent J-L, Cohen J, Opal SM, Glauser M, Parsons P, Fisher CJ Jr, Repine JE (2000) Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a réévaluation. Crit Care Med 28:232-235
40. Solbach W, Mall H, Rollinghoff M (1997) Lymphocytes play the music but the macrophages call the tune. Immunol Today 12:4-6
41. Zehnbauer B A, Freeman BD, Buchman TG (1999) Genetic predisposition to sepsis and organ failure. In: Baue AE, Berlot E, Gullo A (eds) Sepsis and organ dysfunction. Springer, Berlin, Heidelberg, New York, pp 49-53
42. Fang XM, Schröder S, Hoeft A, Stiiber F (1999) Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 27:1330-1334
43. Dinarello CA (1999) Is there an interleukin-1 genetic predisposition to developing severe sepsis? Crit Care Med 27:1397-1398
44. Mira J-P, Cariou A, Grail F, Declaux C, Losser M-R, Heshmati F, Cheval C, Monchi M, Teboul J-L, Riche F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut J-F (1999) Association of TNF2, a TNF-a promoter polymorphism, with septic shock susceptibility and mortality, a multicenter study. JAMA 282:561-568
45. Majetschak M, Flohe S, Obertacke U, Schröder J, Staubach K, Nast-Kolb D, Schade U, Stüber F (1999) Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 230:207-214
46. Bennett-Guererro E, Ayuso L, Hamilton-Davies C, White WD, Barclay GR, Smith PK, King SA, Muhlbaier LH, Newman MF, Mythen MG (1997) Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 277:646-650
47. Hamilton-Davies C, Barclay GR, Cardigan RA, McDonald SJ, Purdy G, Machin SJ, Webb AR (1997) Relationship between preoperative endotoxin immune status, gut perfusion, and outcome from cardiac valve replacement surgery. Chest 112:1189-1196
48. Chaudry I, Ayala A, Ertel W, Stephan RW (1990) Hemorrhage and resuscitation; immunological aspects. Am J Physiol 259:R663-R678
49. Sánchez-Cuenca J, Martin JC, Pellicer A, Simön C (1999) Cytokine pleiotropy and redundancy - gp!30 cytokines in human implantation. Immunol Today 20:57-59
50. Mazolewski PJ, Barber A, Williams S, Simoni J, Davis S, Shires GT (1999) Attenuating tumor necrosis factor a does not ameliorate other cytokine and peroxidase products during sepsis. Am JSurg 178:556-559
51. Davis EG, Eichenberger MR, Polk HC (2000) Microsatellite marker of interferon- y receptor 1 gene correlates with infection following major trauma. Surgery 128:301-305
52. Tannahill CL, Fukuzuka K, Marum T, Abouhamze Z, MacKay SLD, Copeland III EM, Moldawer LL (1999) Discordant tumor necrosis factor-a superfamily gene expression in bacterial peritonitis and endotoxemic shock. Surgery 126:349-357
53. Hübl W, Wolfbauer G, Streicher J, Ändert S, Stanek G, Fitzal S, Bayer PM (1999) Differential expression of tumor necrosis factor receptor subtypes on leukocytes in systemic inflammatory response syndrome. Crit Care Med 27:319-324
54. Schroeder S, Reck M, Hoeft A, Stüber F ( 1999) Analysis of two human leukocyte antigen-linked polymorphic heat shock protein 70 genes in patients with severe sepsis. Crit Care Med 27:1265-1270
55. Aasen AO, Krohn CD, Wang JE (1999) Immunological and inflammatory consequences of surgical trauma. Shock 12 (suppl 1):13
56. De Maio A, Mooney MDL, Matesic LE, Paidas CN, Reeves RH (1998) Genetic component in the inflammatory response induced by bacterial lipopolysaccharide. Shock 10:319-323
57. Kumar A, Short J, Parrillo JE (1999) Genetic factors in septic shock. JAMA 282:579-581
58. Opal SM, Luchi M (1999) New developments in pathophysiology of endotoxins and opportunities for treatment. Curr Opin Crit Care 5:376-380
59. O'Reilly M, Newcomb DE, Remick D (1999) Endotoxin, sepsis, and the primrose path. Shock 12:411-420
60. Hatch T (1998) Chlamydia: old ideas crushed, new mysteries bared. Science 282:638-639
61. Mehta JL (1999) Inflammation, infection, and coronary artery disease. ACC Educational Highlights Winter:! 1-14
62. Grayston JT (1999) Does Chlamydia pneumoniae cause atherosclerosis? ArchSurg 134:930-934
63. Hawker FH (1999) Helicobacter pylori and critical illness: a passive bystander or cause of disease? Crit Care Med 27:1385-1386
64. Meier CR, Derby LE, Jick SS, Vasilakis C, Jick H (1999) Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA 281:427-431
65. Angele MK, Xu YX, Ayala A, Schwacha MG, Catania RK, Cioffi WG, Bland KI, Chaudry IH (1999) Gender dimorphism in trauma-hemorrhage-induced thymocyte apoptosis. Shock 12:316-322
66. Gallagher RB (1999) The male's dilemma. Science 284:1140
67. Eachempati SR, Hydo L, Barie PS (1999) Gender-based differences in outcome with patients with sepsis. ArchSurg 134:1342-1347
68. Crabtree TD Pelletier SJ, Gleason TG, Pruett TL, Sawyer RG (1999) Genderdependent differences in outcome after the treatment of infection in hospitalized patients. JAMA 22:2143-2148
69. Offner PJ, Moore EE, B iff! WL (1999) Male gender is a risk factor for major infections after surgery. Arch Surg 134:935-940
70. Whitacre CC, Reingold SC, O'Looney PA, Task Force on Gender, Multiple Sclerosis and Autoimmunity (1999) A gender gap in autoimmunity. Science 283:1277-1278
71. Upperman JS, Deitch EA, Guo W, Lu Q, Xu D (1999) Post-hemorrhagic shock mesenteric lymph is cytotoxic to endothelial cells and activates neutrophils. Shock 10:407-414.
72. Lemaire LCJM, van Lanschot JJB, Stoutenbeek CP, van Deventer SJH, Dankert J, Oosting H, Gouma DJ (1999) Thoracic duct in patients with multiple organ failure: no major route of bacterial translocation. Ann Surg 229:128-136
73. Moore EE (1998) Mesenteric lymph: the critical bridge between dysfunctional gut and multiple organ failure. Shock 10:415116
74. Shnaper A, Greif F, Micowitz M, Feodorov D, Sorkin P, Lelcuk S (1994) Translocating gut bacteria reach the pulmonary artery by means of the thoracic duct during hemorrhagic shock. Surg Forum 94:72-73
75. Magnotti LJ, Xu D-Z, Lu Q, Deitch EA (1999) Gut-derived mesenteric lymph: a link between burn and lung injury. Arch Surg 134:1333-1341
76. Zimmer S, Heiss MM, Schardey HM, Weilbach CH, Faist E, Lauterjung L ( 1998) Inflammatorisches Syndrom nach endovaskulären Aortenstentimplatationen - eine vergleichende Studie. Langenbeck's Arch Chir (Forumbond) 5:13-17
77. Aziz M, Kirschenbaum LA, Astiz ME, Saha D, Rackow EC (1999) Neutrophil-platelet interactions in sepsis. Crit Care Med 27.-A49
78. Post JC, Ehrlich GD (2000) The impact of the polymerase chain reaction in clinical medicine. JAMA 283:1544-1546
79. Ikegami K, Sakai T, Seki T, Morimoto F, Kubota H, Sato Y (1999) Polymerase chain reaction surveillance of fungal DNA in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 27:A135
80. Lehmann LE, Klaschik S, Raadts A, Paul! M, Schroeder S, Putensen C, Hoeft A, Stuber F (1999) Detection of bacterial DNA in the plasma of patients with sepsis, severe sepsis and multiple organ dysfunction syndrome. Crit Care Med 27: A135
81. Reyes WJ, Brimioulle S, Vincent J-L ( 1999) Septic shock without documented infection: an uncommon entity with a high mortality. Intensive Care Med 25:1267-1270
82. Heeg K, Miethke T, Wagner H (1996) Superantigen-mediated lethal shock: the functional state of ligand-reactive T cells. In: Heeg K, Miethke T, Wagner H (eds) Current Topics of Microbiology. Springer, Heidelberg, pp 83-100
83. Covacci A, Telford JL, Gludice GD, Parsonnet J, Rappuoli R (1999) Helicobacter pylori virulence and genetic geography. Science 284:1328-1333
84. Robertson MS, Cade JF, Clancy RL (1999) Helicobacter pylori infection in intensive care: increased prevalence and a new nosocomial infection. Crit Care Med 27:1276-1280
85. Zallen G, Moore EE, Johnson JL, Tamura DY, Aiboshi J, Abiffl WL, Silliman CC (1999) Circulating postinjury neutrophils are primed for the release of proinflammatory cytokines. J Trauma 46:42-48
86. Botha AJ, Moore FA, Moore EE, Sauaia A, Banerjee A, Peterson VM (1995) Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma 39:41117
87. Botha AJ, Moore FA, Moore EE, Peterson VM, Silliman CC, Goode AW ( 1996) Sequential systemic platelet-activating factor and interleukin 8 primes neutrophils in patients with trauma at risk of multiple organ failure. Br J Surg 83:1407-1412
88. Papathanassoglou EDEE, Moynihan JA, Ackerman MH (2000) Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical framework. Crit Care Med 28:537-549
89. Härtung T, Volk HD, Wendel A (1999) GCSF treatment of normal volunteers induces a sustained immunomodulation characterized by an anti-inflammatory cytokine response. Shock 12:A47
90. Root RK (2000) Granulocyte colonystimulating factor (GCSF) in the treatment of severe pneumonia, sepsis and septic shock. Shock 13:A99
91. Knox J, Demling R, Wilmore D, Sarraf P, Santos A (1999) Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J Trauma 39:526-532
92. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW (1995) A new treatment for patients with shortbowel syndrome: growth hormone, glutamine, and a modified diet. Ann Surg 222:243-255
93. Herndon DN, Hawkins HK, Nguyen TT, Pierre E, Cox R, Barrow RE (1995) Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 221:649-659
94. Yaffe MB, Xu J, Burke PA, Forse A, Brown GE (1999) Priming of the neutrophil respiratory burst is species-dependent and involves MAP kinase activation. Surgery 126:248-254
95. Albert LJ, Inman RD, Epstein FH (1999) Molecular mimicry and autoimmunity. New Engl J Med 341:2068-2074
96. Baue AE, Durham R, Faist E (1998) Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 10:79-89
97. Baue AE (1994) Multiple organ failure, multiple organ dysfunction syndrome, and the systemic inflammatory response syndrome - where do we stand? Shock 2:385-397
98. Levine JH, Durham RM. Moran J, Baue AE (1996) Multiple organ failure: is it disappearing? World J Surg 20:471-473
99. Zimmerman JE, Knaus WA, Wagner DP, Sun X, Hakin RB, Nystrom P-O (1996) A comparison of risks and outcomes of patients with organ system failure: 1982-1990. Crit Care Med 24:1633-1641
100. Regel G, Loberhoffer P, Grotz M, Pape HC, Lehmann U, Tscherne H (1995) Treatment results of patients with multiple trauma: an analysis of 3,406 cases treated between 1972 and 1991 in a German level one trauma center. J Trauma 38:70-80
101. Christou NV, Meakins JL, Gordon J, Yee J, Hassan-Zahraee M, Nohr C, Shizgal H, MacLean L (1995) The delayed hypersensitivity response and host resistance in surgical patients 20 years later. Ann Surg 222:534-548
102. O'Keefe GE, Maier RV, Diehr P, Grossman D, Jurkovich GJ, Conrad D (1997) The complications of trauma and their associated costs in a level I trauma center. Arch Surg 132:920-924
103. O'Keefe GE, Maier RV (1999) Are we winning the battle in the surgical intensive care unit? Crit Care Med 5:308-314
104. Baue AE (1998) The promissory note in scientific research. Am J Surg 175:2-3
105. Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P (1998) Selenium systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med 26:1536-1544
106. Wong HR (1998) Nuclear factors kappa and nitric oxide regulating life and death: nonsense or harsh reality. Crit Care Med 27:1470-1471
107. Goris RJA, Gimbrere JSF, van Niekerk JLM (1982) Early osteosynthesis and prophylactic ventilation in the multi-trauma patient. J Trauma 82:895-897
108. Galbán C, Montejo JC, Mesejo A, Marco P, Celaya S, Sanchez-Segura JM, Farrè JR, Bryg DJ (2000) An immune-enhancing enterai diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 28:643-648
109. Hirasawa H, Sugai T, Oda S, Shiga H, Sadahiro T (1999) Clinical benefits of cytokine removal with continuous hemodiafiltration (CHDF) in critical care. Shock 12:A51
110. Reeves JH, Warwick WB, Shann F, Layton JE, Stewart A, Waring PM, Presneill JJ, Plasmafiltration in Sepsis Study Group (1999) Continuous plasmafiltration in sepsis syndrome. Crit Care Med 27:2096-2104
111. Claridge JA, Crabtree TD, Pelletier SJ, Butler K, Sawyer RG, Young JS (2000) Persistent occult hypoperfusion is associated with a significant increase in infection rate and mortality in major trauma patients. J Trauma 48:8-15
112. Baue AE (1999) Molecular biology and minimal surgery. Curr Opin Crit Care 5:284-289
113. Shoemaker WC, Wo CCJ, Than-gathurai D, Velmahos G, Beizberg H, Asensio JA, Demetriades D (1999) Hemodynamic patterns of survivors and nonsurvivors during high risk elective surgical operations. World J Surg 23:1264-1271
114. Shoemaker WC, Thangathurai D, Wo CCJ, Kuchta K, Canas M, Sullivan MJ, Farlo J, Roffey P, Zellman V, Katz RL (1999) Intraoperative evaluation of tissue perfusion in high-risk patients by invasive and noninvasive hemodynamic monitoring. Crit Care Med 27:2147-2152
115. Durham RM, Neunaba K, Mazuski JE, Shapiro MJ, Baue AE (1996) The use of oxygen consumption and delivery as end points for resuscitation in critically ill patients. J Trauma 41:32-40
116. Goodwin JS (1997) Chaos and the limits of modern medicine. JAMA 278:1399-1400
117. Bernard C (1949) An Introduction to the Study of Experimental Medicine (translated by HC Green). Schuman, New York
118. Cannon WB ( 1932) The Wisdom of the Body. Norton, New York
119. Schultz SG (1996) Homeostasis, humpty dumpty and integrative biology news. Physiol Sei 11:238-246
120. Buchman TG (1996) Physiologic stability and physiologic state. J Trauma 41:599-605
121. Popper K ( 1986) Reductionism and biologic systems. Medawar Lecture, Proceedings of the Royal Society of London
122. Godin PJ, Fleisher LA, Eidsdath A, Vandivier RW, Preas HL, Banks SM, Buchman TG, Suffredini AF (1996) Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized crossover trial. Crit Care Med 24:1117-1124
123. Godin PJ, Buchman TG (1996) Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24:1107-1116
124. Siegel JH, Rixen D, Friedman HP (1995) Physiologic classification and stratification of illness severity of post-trauma "sepsis" patients as a basis for randomization of clinical trials. J Endotox Res 2:177-188
125. Churchill ED (1972) Surgeon to Soldiers. JB Lippincott, Philadelphia
126. Vogel S (1998) Academically correct biology. Am Scientist 86:504-506
127. Latour B (1998) From the world of science to the world of research. Science 280:208-209
128. Lenfant C (1999) Medicine and the new millennium. Science 280:465
129. The Bible: Ecclesiastes 3:1. The Holy Bible of King James Version (1901) National Bible Press, Philadelphia, p 462